Hereditary pancreatitis

Area of Science:

• Genetics and Molecular Biology
• Gastroenterology
• Hereditary Diseases

Background:

• Hereditary pancreatitis is an autosomal dominant disorder causing recurrent acute and chronic pancreatitis, often at a young age.
• The cationic trypsinogen gene (PRSS1) mutations, specifically R122H and N29I, are found in most hereditary pancreatitis cases.
• The R122H mutation is hypothesized to cause pancreatitis by impairing trypsin deactivation, leading to pancreatic autodigestion.

Purpose of the Study:

• To summarize the genetic basis and clinical presentation of hereditary pancreatitis.
• To highlight the diagnostic challenges and the importance of considering hereditary pancreatitis in patients with recurrent pancreatitis and family history.
• To compare the clinical impact of common PRSS1 mutations (R122H vs. N29I) and discuss cancer risks.

Main Methods:

• Review of existing literature on hereditary pancreatitis and PRSS1 gene mutations.
• Analysis of clinical presentations, diagnostic criteria, and outcomes associated with different mutations.
• Assessment of the lifetime risk of pancreatic cancer in hereditary pancreatitis patients.

Main Results:

• Hereditary pancreatitis patients present similarly to sporadic cases but at an earlier age, often with delayed diagnosis.
• The R122H mutation is associated with earlier onset and higher likelihood of surgical intervention compared to N29I.
• Hereditary pancreatitis confers a 40% lifetime risk of pancreatic cancer, particularly in individuals aged 50-70.

Conclusions:

• Hereditary pancreatitis requires consideration in patients with recurrent pancreatitis and a family history of pancreatic disease.
• Genetic testing for PRSS1 mutations can aid in diagnosis and risk stratification.
• Regular screening for pancreatic cancer is important for individuals with hereditary pancreatitis, especially in the 50-70 age group.